⚖️ Pharmaceuticals - Indian - Formulations
Industry peer comparison — 20 companies ranked by market cap. Click any column header to sort; click a symbol for its full fundamentals page.
AI-assisted data: figures are extracted from public quarterly filings with AI assistance,
under human editorial oversight, and may still contain errors — verify against official filings. Educational
information only, not financial advice.
| # | Company | CMP (₹) | MCap (Cr) | P/E | Sales TTM (Cr) | NP TTM (Cr) | OPM % | NPM % | Sales YoY % | NP YoY % | Qtr Rev Δ% | Qtr NP Δ% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 1,032.00 | 20,184 | 67.5 | 1,683 | 297 | 28.4% | 17.7% | 47.7% | 454.9% | 44.9% | 115.2% | |
| 2 | 332.50 | 15,068 | 29.1 | 3,171 | 521 | 22.5% | 16.4% | 12.5% | 9.7% | 35.6% | 174.8% | |
| 3 | 680.50 | 7,236 | 52.9 | 1,005 | 142 | 19.7% | 14.1% | 14.4% | 48.7% | 37.6% | 15.8% | |
| 4 | 507.55 | 6,309 | 26.7 | 852 | 236 | 42.6% | 27.7% | 17.1% | 85.5% | 28.8% | 28.0% | |
| 5 | 1,327.50 | 6,114 | 46.6 | 692 | 131 | 29.5% | 19.0% | 63.0% | 108.7% | 30.6% | 43.8% | |
| 6 | 1,129.50 | 2,331 | 35.7 | 942 | 66 | 11.1% | 7.1% | 18.9% | 9.0% | 18.1% | -0.1% | |
| 7 | 1,651.10 | 2,210 | 19.0 | 811 | 117 | 20.4% | 14.4% | 17.9% | 127.9% | 35.6% | 139.3% | |
| 8 | 23.44 | 2,203 | 1.3 | 12,547 | 1,729 | 15.2% | 13.8% | 2566.9% | 3386.8% | 7.4% | 57.7% | |
| 9 | 2,187.90 | 1,861 | 13.6 | 318 | 137 | 30.8% | 43.0% | 4.7% | 101.2% | -8.4% | 460.8% | |
| 10 | 489.00 | 1,413 | 26.2 | 512 | 54 | 14.4% | 10.5% | 11.0% | 1.3% | 9.5% | -45.4% | |
| 11 | 601.50 | 1,205 | 12.5 | 694 | 97 | 14.6% | 14.0% | 7.6% | 7.2% | 15.1% | 30.9% | |
| 12 | 301.45 | 713 | 91.6 | 143 | 8 | 8.2% | 5.5% | 3.3% | 166.8% | -23.2% | -97.8% | |
| 13 | 198.00 | 692 | 16.1 | 237 | 29 | 15.3% | 12.3% | 18.7% | 20.1% | 4.0% | -13.0% | |
| 14 | 323.80 | 439 | 1.3 | 9,516 | 381 | 10.1% | 4.0% | 5751.8% | 3308.0% | 11.3% | 15.3% | |
| 15 | 137.50 | 225 | 13.7 | 150 | 16 | 12.7% | 11.0% | 25.8% | 34.9% | -30.2% | 47.9% | |
| 16 | 51.05 | 168 | 24.7 | 131 | 7 | 9.1% | 5.2% | 60.2% | 53.1% | -4.2% | 48.5% | |
| 17 | 78.45 | 135 | 41.7 | 171 | 4 | 7.0% | 2.3% | — | — | 40.9% | 100.0% | |
| 18 | 62.32 | 131 | 29.6 | 111 | 4 | 1.7% | 4.0% | -5.9% | -22.5% | 25.2% | -91.7% | |
| 19 | 101.45 | 119 | — | 22 | -3 | -12.9% | -14.0% | — | — | -77.5% | -383.0% | |
| 20 | 33.13 | 54 | 110.4 | 34 | — | 2.3% | 1.4% | -15.0% | 405.5% | 92.1% | -95.5% |
TTM = trailing twelve months. Banks/NBFCs show total income in the sales column.
Live prices refresh about twice a day. Educational information only — not financial advice.
